![Jean-Pierre Sommadossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 31 M $ al 31/07/2026
El Dr. Jean-Pierre Sommadossi es presidente de Kezar Life Sciences, Inc., presidente y director general de Atea Pharmaceuticals, Inc., miembro del Consejo de Descubrimiento de la Facultad de Medicina de Harvard y director independiente de ABG Acquisition Corp. I. Forma parte del Consejo de Administración de Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. y ABG Acquisition Corp. I. El Dr. Sommadossi trabajó anteriormente como presidente y director general de Idenix Pharmaceuticals LLC, cofundador de Pharmasset, Inc., profesor de la Universidad de Alabama en Birmingham, becario Fogarty del Colegio Médico de Virginia, becario Fogarty del Instituto Nacional del Cáncer y asesor de Puretech Health LLC. También formó parte del consejo de Alzheon, Inc. y de Kinex Pharmaceuticals, Inc. Se doctoró en la Universidad de Marsella.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/04/2026 | 6.633.855 ( 8,29 % ) | 31 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Director Ejecutivo | 01/12/2012 |
| ABG ACQUISITION CORP. I | Director/Miembro de la Junta | 01/02/2021 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Director/Miembro de la Junta | 01/01/2004 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Presidente | 01/01/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Presidente | 11/05/2022 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Presidente | 01/01/2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2021 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Director/Miembro de la Junta | 01/11/2020 |
| ATHENEXPAR | Director/Miembro de la Junta | 01/07/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 17 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
